Effect of Blood Storage Age on the Resolution of Lactic Acidosis in Children With Severe Malarial Anemia at Mulago Hospital
NCT01580111 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74
Last updated 2012-04-18
Summary
In resolving lactic acidosis among children with severe malarial anemia, there is no difference between those transfused with blood of longer storage compared to shorter storage age
Conditions
- Compare Blood Age for Transfusion
Interventions
- BIOLOGICAL
-
Blood transfusion
The short storage arm; children were transfused with packed red cells of storage age 1-10 days; while for the Long storage arm; were transfused with packed red cells of 21- 35 days in storage.
Sponsors & Collaborators
-
Makerere University
lead OTHER
Principal Investigators
-
AGGREY DHABANGI, MBChB, M.Med · Makerere University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 59 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2011-08-31
- Completion
- 2011-11-30
Countries
- Uganda
Study Locations
More Related Trials
-
Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia
NCT06285604 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Observation of Luspatercept in Treatment of Chinese Adult β-thalassaemia Patients With TD β-thalassemia
NCT06164821 ·Status: RECRUITING ·Phase: NA
-
Iron Status in BTM With Blood Transfusion
NCT04947540 ·Status: UNKNOWN
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell Transplantation
NCT00789516 ·Status: COMPLETED
-
Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Assiut University Children Hospital
NCT03273998 ·Status: UNKNOWN
-
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia
NCT02604433 ·Status: COMPLETED ·Phase: PHASE3
-
Dermatological Abnormalities in Beta-thalassemia Major
NCT03894605 ·Status: UNKNOWN
-
PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions
NCT02087553 ·Status: COMPLETED
-
Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease
NCT05211037 ·Status: COMPLETED ·Phase: NA
-
The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major
NCT04260516 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study
NCT05462548 ·Status: UNKNOWN ·Phase: PHASE4
-
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967 ·Status: COMPLETED
-
Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital
NCT03161899 ·Status: COMPLETED
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
Safety & Efficacy of Thalidomide in Children With Transfusion Dependent Thalassemia
NCT06098014 ·Status: COMPLETED ·Phase: PHASE1
-
IRON DEFICIENCY ANEMIA IN RELATION TO PINCH STRENGTH AND HAND DEXTERITY IN PRESCHOOL CHILDREN
NCT05959122 ·Status: COMPLETED
-
Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia
NCT05921968 ·Status: UNKNOWN ·Phase: PHASE4
-
Body Composition in Pediatric Patients With Thalassemia Major
NCT07204015 ·Status: NOT_YET_RECRUITING
-
Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children
NCT03133169 ·Status: COMPLETED
-
Screening of Coexistence Between Sickle Cell Anaemia and G6PD Deficiency
NCT06615024 ·Status: NOT_YET_RECRUITING
-
Congenital Heart Surgery in Pediatric Patients With Beta-Thalassemia Major
NCT04367701 ·Status: COMPLETED
-
A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.
NCT05567458 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients
NCT06219239 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia
NCT06678165 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1